Home Family Medicine Walking Difficulty and Leg Swelling

Walking Difficulty and Leg Swelling

📋 Key Information Summary

📋
  • Walking difficulty encompasses abnormal gaits (cerebellar, spastic, foot drop, Trendelenburg), pain-related limping, and mechanical causes — each pattern localises the lesion to a specific anatomical level.
  • Cerebellar gait is wide-based and ataxic with truncal instability; always consider posterior fossa stroke, alcohol, or drug toxicity as urgent differentials.
  • Spastic gait (scissoring, circumduction) indicates upper motor neuron disease (stroke, MS, cerebral palsy); MRI brain/spine is first-line investigation.
  • Foot drop (steppage gait) results from L5 radiculopathy, common peroneal nerve palsy, or peripheral neuropathy — nerve conduction studies differentiate the level.
  • Trendelenburg gait (pelvic drop contralateral to stance leg) points to gluteus medius weakness from superior gluteal nerve injury, hip pathology, or muscular dystrophy.
  • Limp in children must be triaged urgently: septic arthritis of the hip is a surgical emergency requiring aspiration within 6 hours; Perthes disease and slipped capital femoral epiphysis (SCFE) require urgent orthopaedic review.
  • Use the paediatric limping algorithm: age → pain vs painless → fever vs afebrile → bloods (FBC, ESR, CRP, blood culture) → imaging (X-ray ± USS hip) → consider MRI.
  • Leg swelling is broadly divided into unilateral (DVT, cellulitis, venous insufficiency, lymphoedema, Baker's cyst rupture) and bilateral (cardiac failure, renal, hepatic, medication-related, hypothyroidism).
  • DVT — apply Wells score; if unlikely, perform D-dimer; if likely or D-dimer positive, proceed to compression duplex ultrasound. DOACs (apixaban, rivaroxaban) are first-line treatment.
  • Cellulitis — differentiate from DVT; empirical flucloxacillin (or cefazolin if severe); add benzylpenicillin for freshwater exposure (Aeromonas). Consider MRSA cover in ATSI remote communities.
  • Septic arthritis in adults — joint aspiration with Gram stain, crystals, culture is mandatory before antibiotics; empirical IV flucloxacillin + benzylpenicillin (or vancomycin if MRSA risk).
  • Bone tumours presenting with leg pain or swelling require urgent X-ray; if suspicious features (periosteal reaction, cortical destruction, soft-tissue mass), refer to orthopaedic oncology within 72 hours.
  • ATSI populations have higher rates of rheumatic fever, septic arthritis, CA-MRSA skin infections, and delayed presentation — lower clinical suspicion thresholds and ensure culturally safe assessment.

Introduction & Australian Epidemiology

Walking difficulty and leg swelling are among the most common presenting complaints in Australian general practice and emergency departments. The differential diagnosis spans neurological, musculoskeletal, vascular, and systemic causes, and a structured approach to history and examination is essential to avoid missing serious pathology such as septic arthritis, deep vein thrombosis (DVT), or malignancy.

In Australia, falls and mobility limitations affect approximately 30% of adults aged over 65, making gait assessment a core component of the annual 75+ health assessment (MBS Item 707). Among children, an acute limp accounts for roughly 4 per 1,000 emergency presentations per year, with transient synovitis the most common cause (up to 80%) but septic arthritis (2–5%) requiring urgent exclusion.

Leg swelling as a presenting complaint carries significant diagnostic breadth. Venous thromboembolism (VTE) affects approximately 30,000 Australians annually, with incidence increasing with age, obesity, and hospitalisation. Lymphoedema is estimated at over 500,000 Australians, with primary forms presenting in younger adults and secondary forms commonly following cancer treatment. Chronic venous disease affects up to 30% of the adult population.

This article provides a comprehensive clinical guide to the assessment, investigation, and management of walking difficulty — including the major gait abnormalities and the paediatric limp — and leg swelling, with a focus on Australian clinical practice, PBS-listed medications, MBS-relevant investigations, and specific consideration for Aboriginal and Torres Strait Islander communities.

Abnormal Gaits

Gait assessment is a fundamental clinical skill. The pattern of abnormality provides immediate localisation of pathology. Observe the patient walking at normal pace, on heels, on toes, and tandem (heel-to-toe) walking. Note cadence, stride length, arm swing, trunk stability, and foot clearance.

Gait Pattern Key Features Anatomical Localisation Common Causes (Australia)
Cerebellar (ataxic) Wide-based, staggering, truncal instability, difficulty with tandem gait, no improvement with visual fixation Cerebellar vermis or hemispheres Alcohol cerebellar degeneration, posterior fossa stroke, MS, medications (phenytoin), spinocerebellar ataxia, posterior fossa tumour
Spastic (upper motor neuron) Scissoring, circumduction of affected leg, stiff-legged, foot dragging, hyperreflexia, upgoing plantars Corticospinal tract (brain or spinal cord) Stroke (ischaemic/haemorrhagic), cerebral palsy, MS, spinal cord compression, hereditary spastic paraplegia, motor neurone disease
Foot drop (steppage) High-stepping gait to clear the foot; slapping foot strike; inability to walk on heels L5 nerve root, common peroneal nerve, or distal peripheral nerve L4/5 disc prolapse, common peroneal nerve palsy (fibular head fracture, prolonged positioning), peripheral neuropathy (diabetes), MND, Charcot-Marie-Tooth
Trendelenburg Pelvic drop on contralateral side during stance phase; may adopt compensated (waddling) gait with trunk lean to affected side Gluteus medius/minimus — superior gluteal nerve or hip abductor mechanism Hip osteoarthritis, superior gluteal nerve injury (surgery, injection), muscular dystrophy, developmental dysplasia of hip, L5 radiculopathy
Antalgic Shortened stance phase on affected leg, increased speed of swing phase, limping Pain generator — joint, bone, or soft tissue Hip/knee OA, fracture, septic arthritis, osteomyelitis, referred pain (L3/4 radiculopathy → knee pain)
Parkinsonian Shuffling, short stride, reduced arm swing, festination (progressive acceleration), freezing, stooped posture Basal ganglia (substantia nigra) Parkinson's disease, drug-induced parkinsonism (metoclopramide, antipsychotics), vascular parkinsonism, normal pressure hydrocephalus

Cerebellar Gait — Detailed Assessment

A wide-based ataxic gait with lateral sway and inability to perform tandem walking strongly suggests cerebellar dysfunction. The patient cannot stand with feet together (Romberg test is negative — they fall even with eyes open). Distinguish from sensory ataxia (positive Romberg — worsens with eyes closed, due to posterior column or large-fibre peripheral neuropathy).

⚠️
Red flags for acute cerebellar ataxia: Sudden onset of ataxia in an adult must be treated as a posterior fossa stroke (cerebellar infarction or haemorrhage) until proven otherwise. Urgent CT brain (± CT angiography) is required. Cerebellar haemorrhage can cause rapid brainstem compression and death — neurosurgical consultation is mandatory.

Investigations: MRI brain (gold standard for posterior fossa pathology), FBC, UEC, LFTs, TFTs, vitamin B12/thiamine, blood alcohol level, urine drug screen. Consider genetic testing if family history of spinocerebellar ataxia.

Spastic Gait — Detailed Assessment

Spastic gait reflects upper motor neuron (UMN) pathology. The leg is held stiffly in extension and adduction, with circumduction during swing phase. Tone is increased (clasp-knife), reflexes are brisk, and plantar responses are extensor (Babinski positive). If unilateral, consider stroke; if bilateral, consider spinal cord pathology (compressive myelopathy, MS, hereditary spastic paraplegia).

Urgent MRI of the brain (if unilateral) or full spine (if bilateral or level unclear) is the investigation of choice. Do not delay MRI if cord compression is suspected — dexamethasone 8 mg IV/PO BD should be initiated immediately as a holding measure.

Foot Drop (Steppage Gait)

Foot drop results from weakness of ankle dorsiflexion (tibialis anterior). The patient compensates by excessive hip and knee flexion during swing phase to clear the foot. Test ankle dorsiflexion (L4–L5), great toe extension (L5), and eversion (L5–S1). Examine sensation over the dorsum of the foot (superficial peroneal nerve) and lateral shin (common peroneal nerve distribution).

Determine the level of the lesion:

  • Peripheral nerve (common peroneal): Check for fibular head tenderness, history of leg crossing, plaster cast, or prolonged lithotomy position. EMG/NCS confirms localised conduction delay.
  • L5 radiculopathy: Associated back pain, dermatomal sensory loss over dorsum of foot and lateral leg, weakness of hip abduction (gluteus medius). MRI lumbosacral spine confirms.
  • Peripheral neuropathy: Often bilateral, stocking distribution sensory loss, distal weakness. Check HbA1c, B12, serum protein electrophoresis, nerve conduction studies.
  • Central (UMN): Spasticity, brisk reflexes, extensor plantars — consider stroke, MND, MS.

Management: Ankle-foot orthosis (AFO) — available through public hospital orthotics departments or NDIS-funded services. Treat underlying cause. Physiotherapy for gait retraining.

Trendelenburg Gait

Weakness of the gluteus medius and minimus (hip abductors) results in inability to stabilise the pelvis during single-leg stance. The pelvis drops on the contralateral side. In a compensated Trendelenburg gait, the patient leans the trunk over the affected hip to shift the centre of gravity and reduce the abductor demand — this may be mistaken for a "waddle."

Causes include hip osteoarthritis (pain inhibition), superior gluteal nerve injury (post-hip surgery or misplaced intramuscular injection — always inject into the upper outer quadrant), L5 radiculopathy, and muscular dystrophy (fascioscapulohumeral, limb-girdle).

Investigations: X-ray pelvis (AP, frog-leg lateral) for hip OA or DDH; MRI hip for labral tear, tendinopathy; MRI lumbosacral spine for L5 radiculopathy; CK and EMG if myopathy suspected.

Limp in Children — Diagnostic Model

A child presenting with a limp is a common but potentially serious presentation. The approach must be systematic, age-appropriate, and mindful that young children may not localise pain accurately (referred hip pain often presents as knee pain).

Age-Based Differential Diagnosis

Age Group Common Causes Key Differentials
Toddler (1–3 years) Toddler's fracture (spiral tibial fracture from trivial trauma), transient synovitis Septic arthritis, osteomyelitis, neuroblastoma, abuse
Pre-school (3–6 years) Transient synovitis, septic arthritis, osteomyelitis Perthes disease, leukaemia, reactive arthritis
School-age (6–12 years) Transient synovitis, Perthes disease, trauma Septic arthritis, osteosarcoma, Ewing sarcoma, Osgood-Schlatter
Adolescent (12–16 years) Slipped capital femoral epiphysis (SCFE), sports injury, Osgood-Schlatter Septic arthritis, bone tumour, avascular necrosis, stress fracture

Clinical Assessment Algorithm

1
Is the child unwell or systemically septic?
Fever >38.5°C, refusal to weight-bear, irritability, toxic appearance → suspect septic arthritis or osteomyelitis. Proceed immediately to bloods + imaging + orthopaedic consult.
2
Is there pain or is the limp painless?
Painless limp → consider cerebral palsy, muscular dystrophy, leg length discrepancy, developmental coordination disorder. Painful limp → proceed to step 3.
3
Where is the pain? Examine the whole chain.
Hip (limited internal rotation, pain on log-roll), knee (always examine hip if knee pain — referred pain), back, foot/ankle. Check for knee effusion (Baker's cyst in children can present similarly).
4
Order targeted investigations
FBC, ESR, CRP, blood culture (if febrile). X-ray pelvis AP + frog-leg lateral. Ultrasound hip for effusion. MRI if X-ray normal and concern persists.

Distinguishing Transient Synovitis from Septic Arthritis

This is the most critical clinical decision in the limping child. Use the Kocher criteria to stratify risk:

Kocher Criterion Points
Temperature ≥ 38.5°C 1
Inability to weight-bear 1
ESR ≥ 40 mm/hr 1
WBC ≥ 12.0 × 10⁹/L 1
Low Risk
0 criteria
Probability of septic arthritis <2%. Likely transient synovitis. Observe with analgesia and review in 48 hours.
Setting: GP / ED discharge with safety-netting
Moderate Risk
1–2 criteria
Probability 3–40%. Ultrasound-guided hip aspiration recommended. Admit for observation, IV antibiotics if aspirate positive.
Setting: ED / paediatric admission
High Risk
3–4 criteria
Probability >90% for septic arthritis. Urgent surgical aspiration ± washout under general anaesthesia. Start empirical IV antibiotics immediately.
Setting: Theatre / paediatric intensive care
🚨
Septic arthritis of the hip is a surgical emergency. Delay in aspiration and drainage beyond 6 hours increases the risk of avascular necrosis, growth plate damage, and permanent disability. Do not wait for blood results if clinical suspicion is high — start IV antibiotics and arrange urgent orthopaedic review.

Investigations for the Limping Child

Essential X-ray pelvis AP + frog-leg lateral First-line imaging. Identifies fractures, Perthes (crescent sign, femoral head lucency), SCFE (widened physis, Klein's line), bone tumours. Normal X-ray does not exclude early septic arthritis or osteomyelitis.
Available Ultrasound hip (with Doppler) Detects joint effusion (anterior synovial fold >5 mm asymmetry). Cannot distinguish septic from reactive effusion. Useful for guiding aspiration. Available in most Australian EDs and radiology practices.
Available FBC, ESR, CRP, blood culture Inflammatory markers support but do not confirm diagnosis. Blood cultures positive in ~40% of haematogenous septic arthritis. CRP is more sensitive and specific than ESR in children. MBS items apply for bulk-billed paediatric pathology.
Referral MRI hip / pelvis Gold standard for early osteomyelitis, stress fractures, soft-tissue tumours. Requires general anaesthesia in young children. Available at major paediatric centres (RCH Melbourne, Westmead, QCH Brisbane, PMH Perth).
Specialist Bone scan (Tc-99m MDP) Useful when MRI is unavailable or when multifocal osteomyelitis is suspected. Lower specificity than MRI. Available at most nuclear medicine departments in metropolitan centres.
Specialist Aspiration of hip joint Diagnostic and therapeutic. Ultrasound-guided in ED or theatre. Send for Gram stain, culture, cell count (>50,000 WBC/mm³ strongly suggests septic arthritis), and crystal analysis. Orthopaedic procedural.

Leg Swelling & Oedema — Causes and Approach

Leg swelling has a broad differential diagnosis. The first clinical distinction is between unilateral and bilateral swelling, which immediately narrows the differential. The second distinction is between pitting (compressible, leaving an indent — oedema) and non-pitting (firm, brawny — lymphoedema, myxoedema).

Unilateral vs Bilateral Causes

Unilateral Bilateral
Deep vein thrombosis (DVT) Congestive cardiac failure (right heart failure, cor pulmonale)
Cellulitis / erysipelas Chronic venous insufficiency (bilateral may be asymmetric)
Chronic venous insufficiency (often bilateral but asymmetric) Nephrotic syndrome / renal failure
Lymphoedema (can be bilateral) Hepatic cirrhosis (hypoalbuminaemia)
Baker's cyst rupture ("pseudothrombophlebitis") Medication-related (amlodipine, NSAIDs, corticosteroids, gabapentin, pioglitazone)
Muscle tear / haematoma Hypothyroidism (myxoedema — non-pitting)
Compartment syndrome Obesity / dependent oedema / immobility
Superficial thrombophlebitis Lymphoedema (primary or secondary)
Popliteal vein aneurysm Iliac vein compression (May-Thurner — left sided, presents unilaterally)

Clinical Approach to Leg Oedema

1
History: Onset, laterality, associated symptoms
Acute (<72 h) unilateral swelling → DVT, cellulitis, ruptured Baker's cyst, muscle tear. Gradual bilateral → CCF, renal, hepatic, medication. Ask about recent surgery, immobilisation, malignancy, travel, medication changes.
2
Examine: Pitting vs non-pitting, skin changes, pulses, JVP, heart, lungs, abdomen
Pitting: cardiac/renal/hepatic/venous. Non-pitting: lymphoedema, myxoedema. Check for Homan's sign (unreliable), calf tenderness, erythema, warmth. Measure limb circumference 15 cm below tibial tuberosity.
3
Risk stratify for DVT
Apply Wells score for DVT (see below). This determines whether to proceed to D-dimer or directly to imaging.
4
Investigate based on clinical probability
DVT unlikely + negative D-dimer → DVT excluded. DVT likely or D-dimer positive → compression duplex ultrasound. Bilateral oedema → FBC, UEC, LFTs, albumin, TFTs, urinalysis (protein), BNP/NT-proBNP, echocardiogram.

Wells Score for DVT

Criterion Points
Active cancer (treatment within 6 months or palliative) +1
Paralysis, paresis, or recent plaster immobilisation of leg +1
Recently bedridden >3 days or major surgery within 12 weeks +1
Localized tenderness along deep venous system +1
Entire leg swollen +1
Calf swelling ≥3 cm compared to asymptomatic side +1
Pitting oedema confined to symptomatic leg +1
Collateral superficial veins (non-varicose) +1
Previously documented DVT +1
Alternative diagnosis at least as likely as DVT −2

Score interpretation: ≤1 = DVT unlikely (prevalence ~5%) — perform D-dimer. ≥2 = DVT likely (prevalence ~17–50%) — proceed directly to compression duplex ultrasound.

⚠️
D-dimer limitations: D-dimer has high sensitivity but low specificity. It is most useful to exclude DVT in low-risk patients. Do not use D-dimer in patients with active cancer, pregnancy, recent surgery (<2 weeks), or age >80 — false-positive rates are too high. Use age-adjusted D-dimer cutoff (age × 10 µg/L) in patients over 50 years.

Specific Conditions

Septic Arthritis

Septic arthritis is a joint infection requiring urgent diagnosis and treatment. In Australia, Staphylococcus aureus (including CA-MRSA, which accounts for 30–50% of community S. aureus isolates in some regions) is the most common pathogen in adults. Neisseria gonorrhoeae should be considered in sexually active young adults. In children, S. aureus, Streptococcus pyogenes, and Kingella kingae (under 4 years) predominate.

🚨
Do NOT give antibiotics before joint aspiration unless the patient is septic or immunocompromised. Pre-treatment with antibiotics reduces culture yield significantly. In the septic patient, take blood cultures first, start empirical antibiotics, and proceed to aspiration within 1 hour.

Diagnosis

  • Joint aspiration: synovial fluid WBC >50,000/mm³ (highly suggestive), >100,000/mm³ almost diagnostic
  • Synovial Gram stain positive in ~50% of non-gonococcal septic arthritis
  • Blood cultures positive in ~40% of cases
  • CRP typically >100 mg/L; ESR >40 mm/hr; procalcitonin may be elevated

Empirical Antibiotic Therapy

💊
Flucloxacillin
Staphcillin® · Staphylex® · β-lactamase-resistant penicillin
Adult dose 2 g IV every 6 hours (for septic arthritis/severe infection)
Paediatric dose 50 mg/kg IV every 6 hours (max 2 g per dose)
Renal adjustment No adjustment required — hepatically metabolised
PBS status ✔ PBS General Benefit
💊
Vancomycin
Vancocin® · Glycopeptide
Adult dose 15–20 mg/kg IV every 8–12 hours; trough target 15–20 mg/L
Paediatric dose 15 mg/kg IV every 6 hours (neonates: dosing by gestational age)
Renal adjustment Reduce dose/interval when eGFR <50 mL/min — consult pharmacy for AUC-guided dosing
PBS status ✔ PBS General Benefit
💊
Ceftriaxone
Rocephin® · Third-generation cephalosporin
Adult dose 1–2 g IV once daily
Paediatric dose 50 mg/kg IV once daily (max 2 g)
Indication Add for suspected gonococcal arthritis; also used in children <4 years for Kingella kingae coverage
PBS status ✔ PBS General Benefit
ℹ️
MRSA risk: Add vancomycin to the empirical regimen if the patient is from a remote community (e.g., Central Australia, Northern Territory) where CA-MRSA rates are high (>50% of S. aureus), has had recent hospitalisation, or has known MRSA colonisation. Do not use flucloxacillin alone in these settings. Consider trimethoprim+sulfamethoxazole (TMP-SMX) for oral step-down if MRSA confirmed.

Perthes Disease (Legg-Calvé-Perthes)

Perthes disease is avascular necrosis of the femoral head in children, typically aged 4–10 years. It is more common in boys (M:F 4:1). Presentation is insidious — atraumatic limp with hip or referred knee pain, limited hip abduction and internal rotation. Bilateral in ~10–15% of cases (if bilateral and symmetric, consider multiple epiphyseal dysplasia).

Investigation and Staging

  • X-ray pelvis AP + frog-leg lateral: Initial radiograph may be normal (weeks 1–3). Early signs: lateral subluxation (increased medial joint space), subchondral fracture (crescent sign), femoral head sclerosis.
  • MRI with gadolinium: Most sensitive for early diagnosis. Assess for femoral head viability and extent of involvement.
  • Staging (Waldström / Catterall / Herring lateral pillar): Guides prognosis and management. Herring B and C involvement have worse long-term outcomes.

Management

  • Containment principle: The femoral head must be contained within the acetabulum to remodel concentrically. Options: physiotherapy, Petrie casting, femoral osteotomy, Salter innominate osteotomy.
  • Physiotherapy: Maintain hip range of motion (abduction, internal rotation). Avoid weight-bearing if painful (crutches).
  • Surgical indication: Herring B/C border or C involvement in children >6 years. Refer to paediatric orthopaedic surgeon.
  • Prognosis: Most children <6 years with Herring A/B do well with conservative management. Older children and those with extensive head involvement are at risk for premature hip OA.

Bone Tumours — Red Flags and Referral

Primary bone tumours are rare but must be considered in any child or young adult with persistent bone pain, especially if worse at night, associated with a mass, or not explained by trauma. In Australia, the most common primary malignant bone tumours in children and adolescents are osteosarcoma (peak 10–25 years) and Ewing sarcoma (peak 5–20 years).

🚨
Bone tumour red flags — refer urgently:
  • Persistent or worsening bone pain, especially nocturnal, not attributable to trauma
  • Palpable bony swelling or soft-tissue mass
  • Pathological fracture through a lytic lesion
  • X-ray showing periosteal reaction (sunburst, Codman triangle), cortical destruction, or soft-tissue mass
  • Unexplained elevated ALP (bony isoenzyme), ESR, or LDH
Do NOT perform biopsy at a non-specialist centre. Refer to an orthopaedic oncology centre (e.g., Peter MacCallum, RPA, Sir Charles Gairdner). An inappropriate biopsy may compromise limb-salvage surgery.

Initial Workup

  • X-ray of the affected area in two planes (AP + lateral)
  • If suspicious → urgent referral to orthopaedic oncology within 72 hours
  • Staging CT chest, whole-body MRI or PET-CT, and biopsy performed at the specialist centre
  • FBC, UEC, LFTs, ALP (bony isoenzyme), LDH, calcium, phosphate

Benign Bone Lesions Presenting with Leg Swelling or Pain

Lesion Age X-ray Features Management
Unicameral bone cyst 5–15 years Central lucency in proximal humerus or femur; "fallen fragment" sign if pathological fracture Observation if small; steroid injection or curettage + graft if large or fracture risk
Osteochondroma 10–30 years Bony outgrowth with cortical and medullary continuity from parent bone Observation unless symptomatic, growing, or causing nerve compression
Osteoid osteoma 5–25 years Small radiolucent nidus (<2 cm) with surrounding sclerosis; cortical thickening NSAIDs for pain; radiofrequency ablation if refractory
Non-ossifying fibroma (fibrous cortical defect) 5–20 years Eccentric, well-defined lucency in metaphysis of distal femur or proximal tibia Almost always incidental; observation. Curettage if >50% cortical diameter (fracture risk)

Deep Vein Thrombosis — Management

DVT management has been transformed by direct oral anticoagulants (DOACs), which are now first-line for most patients with confirmed DVT. Initial anticoagulation should be commenced as soon as DVT is confirmed (or strongly suspected) while awaiting imaging results in high-risk patients.

💊
Apixaban
Eliquis® · Factor Xa inhibitor
Adult dose 10 mg PO BD for 7 days, then 5 mg PO BD for at least 3 months
Renal adjustment No dose adjustment in renal impairment (minimal renal clearance). Avoid if CrCl <15 mL/min or dialysis.
Hepatic adjustment Avoid in severe hepatic impairment (Child-Pugh C)
PBS status ⬤ PBS Authority Required
💊
Rivaroxaban
Xarelto® · Factor Xa inhibitor
Adult dose 15 mg PO BD with food for 21 days, then 20 mg PO daily with food for at least 3 months
Renal adjustment Avoid if CrCl <15 mL/min. Use with caution if CrCl 15–30 mL/min.
PBS status ⬤ PBS Authority Required
💊
Enoxaparin (as bridge)
Clexane® · Low-molecular-weight heparin
Adult dose 1.5 mg/kg SC once daily OR 1 mg/kg SC every 12 hours
Renal adjustment Reduce to 1 mg/kg SC daily if CrCl <30 mL/min. Prefer unfractionated heparin if CrCl <15 mL/min.
Indication Bridge to warfarin; initial treatment when DOACs contraindicated; cancer-associated VTE (LMWH is preferred for active cancer)
PBS status ✔ PBS General Benefit

Duration of Anticoagulation

Scenario Duration
Provoked DVT (transient risk factor: surgery, immobilisation, OCP) 3 months
First unprovoked DVT ≥3 months, then reassess. Consider extended anticoagulation if bleeding risk is low.
Recurrent unprovoked VTE Extended (indefinite) anticoagulation
Cancer-associated VTE At least 6 months or duration of active cancer. LMWH or DOAC (apixaban/rivaroxaban preferred over edoxaban).
Isolated distal (calf) DVT Consider serial monitoring if low-risk; anticoagulate 3 months if symptomatic or high-risk features.
⚠️
Pulmonary embolism risk: All patients with confirmed DVT should be assessed for PE symptoms (dyspnoea, pleuritic chest pain, tachycardia, haemoptysis). If clinical concern, perform CT pulmonary angiography (CTPA). Massive PE with haemodynamic instability requires systemic thrombolysis (alteplase 100 mg IV over 2 hours) and ICU admission.

Cellulitis & Soft Tissue Infections

Cellulitis is a common cause of unilateral leg swelling and erythema. It is a clinical diagnosis — there is no single confirmatory test. It must be distinguished from DVT (which can coexist), gout, and necrotising fasciitis (surgical emergency).

Clinical Features

  • Erythema, warmth, swelling, tenderness with poorly defined borders
  • Often preceded by breaks in skin (tinea pedis, wounds, insect bites, venous eczema)
  • Regional lymphadenopathy (inguinal nodes for lower limb)
  • Systemic features: fever, malaise, raised inflammatory markers

Red Flags Requiring Urgent Admission

🚨
Suspect necrotising fasciitis if: pain out of proportion to skin findings, rapidly spreading erythema, crepitus, skin blistering/necrosis, systemically unwell (sepsis), failure to respond to IV antibiotics within 24–48 hours. Immediate surgical debridement is life-saving. Do not delay for imaging — if clinical suspicion is high, proceed to exploratory surgery.

Empirical Antibiotic Therapy for Cellulitis

💊
Flucloxacillin
Staphcillin® · First-line for non-purulent cellulitis
Mild (oral) 500 mg–1 g PO QDS for 5–7 days (severe: 7–10 days)
Moderate–Severe (IV) 2 g IV every 6 hours
PBS status ✔ PBS General Benefit
💊
Cefalexin
Keflex® · First-generation cephalosporin · Penicillin allergy alternative
Adult dose 500 mg PO every 8 hours for 7–10 days
Note Use if penicillin allergy is non-anaphylactic (rash only). Avoid in immediate (Type I) penicillin allergy.
PBS status ✔ PBS General Benefit
💊
Trimethoprim + Sulfamethoxazole
Bactrim® · Resprim® · MRSA-active oral agent
Adult dose 160/800 mg PO BD (double strength)
Indication Purulent cellulitis (abscess present) or confirmed CA-MRSA. Often combined with cefalexin for broader streptococcal coverage.
PBS status ✔ PBS General Benefit

Prevention of Recurrent Cellulitis

  • Treat tinea pedis (terbinafine cream or oral terbinafine 250 mg daily for 2 weeks)
  • Emollient to dry/cracked skin (barrier protection)
  • Compression stockings (if chronic venous insufficiency)
  • Prophylactic antibiotics: phenoxymethylpenicillin 250 mg PO BD or erythromycin 250 mg PO BD for 12 months (PBS Authority Required) — indicated after ≥2 episodes per year
  • Lymphoedema management (compression, manual lymphatic drainage, skin care)

Monitoring & Follow-Up

Day 0–1
Initial assessment, investigations, commence treatment. For DVT: commence anticoagulation. For cellulitis: mark erythema margins with pen to track progression. For suspected septic arthritis: urgent aspiration and IV antibiotics.
Day 2–3
Review inflammatory markers (CRP expected to peak then fall with effective treatment). Assess clinical response: decreasing erythema, swelling, pain, fever. If worsening, reconsider diagnosis (necrotising fasciitis, DVT coexistence, resistant organism, antibiotic non-compliance).
Day 5–7
IV-to-oral switch for cellulitis when: afebrile >24 hours, CRP trending down, erythema resolving, tolerating oral intake. For septic arthritis: joint washout may need repeating if persistent effusion.
Week 2–4
Complete antibiotic course. Review DVT anticoagulation compliance. Arrange follow-up duplex ultrasound for iliofemoral DVT at 6 weeks to assess for residual thrombus. Screen for post-thrombotic syndrome.
Month 3+
Reassess duration of anticoagulation for DVT (risk-benefit of continuing vs stopping). For Perthes disease: serial X-rays every 3–4 months through the disease course (duration 2–4 years). For bone tumours: ongoing oncological surveillance.

Special Populations

🤰 Pregnancy
DVT risk is 5–10× higher in pregnancy and postpartum
Wells score and D-dimer are less reliable. Low threshold for compression duplex ultrasound. Left-sided DVT more common (iliac vein compression by gravid uterus).
Anticoagulation: LMWH (enoxaparin) is first-line — DOACs are contraindicated in pregnancy
Dose: enoxaparin 1 mg/kg SC every 12 hours. Adjust for weight gain. Switch to unfractionated heparin at 36 weeks (planned delivery). Warfarin is contraindicated in first trimester (teratogenic) but may be used in second trimester for mechanical valves.
Cellulitis antibiotics: flucloxacillin is safe in pregnancy (Category A)
Avoid doxycycline (Category D), TMP-SMX (Category C — avoid near term), and fluoroquinolones.
👶 Paediatrics
Limping child: see dedicated subtopic above
Septic arthritis in neonates may present subtly (pseudoparalysis, irritability, poor feeding). Group B strep and Gram-negative bacilli are additional neonatal pathogens.
DVT in children is rare — consider central venous line, malignancy, thrombophilia
LMWH is first-line anticoagulant in paediatrics. Warfarin is second-line. DOACs have limited paediatric data.
Oedema: nephrotic syndrome is the most common cause of bilateral oedema in children
Check urine protein:creatinine ratio, serum albumin. Refer to paediatric nephrology.
👴 Elderly (≥65 years)
Falls risk assessment: multifactorial gait assessment (Timed Up and Go, Tinetti)
Review medications contributing to gait disturbance (sedatives, antihypertensives causing orthostatic hypotension, opioids). Home Medicines Review (MBS Item 900) should be offered.
DVT: DOACs preferred over warfarin in the elderly (no INR monitoring, lower ICH risk)
Age-adjusted D-dimer cutoff (age × 10 µg/L for those >50 years). Falls risk with anticoagulation — assess bleeding risk (HAS-BLED score) and ensure home safety.
Bilateral oedema: common and often multifactorial
Medication review (amlodipine — common cause), venous insufficiency, immobility, hypoalbuminaemia. Avoid aggressive diuresis — risk of pre-renal AKI and electrolyte disturbance.
🫘 Renal Impairment
Nephrotic syndrome: bilateral oedema, hypoalbuminaemia, proteinuria >3.5 g/day
Compression stockings, fluid restriction, dietary salt restriction (<5 g/day). Diuretics: frusemide ± metolazone. Refer to nephrology for biopsy.
DVT treatment: enoxaparin dose reduction if CrCl <30 mL/min
Apixaban has minimal renal clearance — preferred DOAC in renal impairment. Avoid rivaroxaban if CrCl <15 mL/min.
Antibiotic dosing: reduce vancomycin interval; avoid gentamicin if possible; adjust flucloxacillin dose in severe hepatic/renal combined failure
Use Cockcroft-Gault or CKD-EPI for eGFR estimation. Therapeutic drug monitoring for vancomycin (trough levels).
🫁 Hepatic Impairment
Cirrhosis with hypoalbuminaemia: bilateral dependent oedema
Spironolactone 100 mg PO daily (first-line diuretic — targets secondary hyperaldosteronism). Add frusemide 40 mg PO daily if insufficient response (maintain spironolactone:frusemide ratio 100:40 to avoid electrolyte imbalance).
Anticoagulation in liver disease: increased bleeding risk
LMWH preferred over DOACs if INR is unreliable (Child-Pugh B/C). DOACs contraindicated in Child-Pugh C cirrhosis. Consult hepatology.
🛡️ Immunocompromised
Expanded differential for gait abnormality and leg swelling
Consider opportunistic infections (mycobacterial, fungal), atypical septic arthritis (including Gram-negatives, Salmonella in sickle cell disease), non-Hodgkin lymphoma presenting as bone pain, and medication effects (calcineurin inhibitors causing gout).
Cellulitis: broadened empiric coverage required
IV piperacillin+tazobactam + vancomycin for severe infection in immunocompromised patients. Consider Gram-negative and atypical coverage. Blood cultures prior to antibiotics are essential.

Aboriginal and Torres Strait Islander Health

Aboriginal and Torres Strait Islander Health Considerations
Rheumatic fever & rheumatic heart disease (RHD)
ATSI Australians, particularly in remote Northern Territory, Queensland, and Western Australia communities, have among the highest rates of acute rheumatic fever (ARF) and RHD globally (incidence up to 170/100,000 in NT Indigenous children). ARF can present with arthritis (migratory polyarthritis of large joints) that may mimic septic arthritis. Always check for preceding sore throat or skin sores. Echocardiography is recommended. RHD prophylaxis (benzathine penicillin G 1.2 MU IM every 28 days) is managed through RHDAustralia registers.
CA-MRSA prevalence
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) accounts for up to 50–70% of community S. aureus isolates in some remote ATSI communities. Empirical flucloxacillin alone is inadequate for suspected septic arthritis or severe cellulitis in these settings — add vancomycin or use empirical MRSA-active regimen (vancomycin + ceftriaxone). Skin sores and scabies are endemic and contribute to recurrent soft tissue infections and post-streptococcal glomerulonephritis.
Remote access barriers
Many ATSI communities are >500 km from the nearest hospital with orthopaedic surgery or advanced imaging. Telehealth consultations (MBS Items 99–114 for video consultations), Royal Flying Doctor Service (RFDS) retrieval, and remote point-of-care testing (CRP, ultrasound) are essential components of care. Aboriginal health practitioners and health workers are critical in facilitating early recognition and transport decisions.
Health literacy and cultural safety
Use plain language, visual aids, and interpreters where English is not the first language (many ATSI Australians speak English as a second, third, or fourth language). Family-centred care is important — involve family in discussions. Avoid assumptions about compliance — barriers are often structural (distance, transport, housing, cost) rather than individual. The 715 health check (MBS Item 715) provides an opportunity for musculoskeletal screening.
Chronic disease burden
ATSI Australians have higher rates of diabetes (3–4× non-Indigenous), chronic kidney disease, cardiovascular disease, and obesity — all contributing to leg oedema, peripheral vascular disease, and impaired wound healing. Diabetic foot disease and peripheral neuropathy are significant contributors to gait abnormality and falls. Ensure comprehensive chronic disease management through GP Management Plans (MBS Item 721) and Team Care Arrangements (MBS Item 723).
Septic arthritis and osteomyelitis
Rates of haematogenous osteomyelitis and septic arthritis are significantly higher in ATSI children. Delayed presentation is common. S. aureus (including MRSA) is the predominant pathogen. Treatment courses may need to be longer (4–6 weeks for osteomyelitis). Ensure follow-up is arranged before discharge from tertiary centres, with clear communication to local health services.

Quick Reference — Gait Patterns & Key Investigations

Cerebellar gait
No specific drug — treat cause
MRI brain (gold standard)
Rule out posterior fossa stroke urgently
Spastic gait
Baclofen 5–25 mg PO TDS
MRI brain/spine
Dexamethasone 8 mg IV/PO BD if cord compression
Foot drop
AFO orthosis + treat cause
NCS/EMG → MRI lumbosacral spine
Check common peroneal nerve at fibular head
Trendelenburg gait
Physiotherapy ± hip surgery
X-ray pelvis → MRI hip
Gluteus medius strengthening; exclude L5 radiculopathy
Childhood limp (transient synovitis)
Ibuprofen 10 mg/kg PO TDS
X-ray pelvis + USS hip
Self-limiting (1–2 weeks); exclude septic arthritis first
DVT
Apixaban 10 mg BD → 5 mg BD
Wells score → D-dimer → CUS
3 months minimum; extended if unprovoked + low bleed risk
Cellulitis
Flucloxacillin 500 mg–1 g PO QDS
Clinical diagnosis; mark margins
Add TMP-SMX if purulent or CA-MRSA suspected
Septic arthritis
Flucloxacillin 2 g IV 6-hrly + vancomycin
Aspirate first → FBC, CRP, culture
Surgical emergency — washout within 6 hours

📚 References

  1. 1. Australian Institute of Health and Welfare (AIHW). Aboriginal and Torres Strait Islander Health Performance Framework. Canberra: AIHW; 2023.
  2. 2. RHD Australia (ARF/RHD writing group). The 2020 Australian Guideline for Prevention, Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease. 3rd ed. Menzies School of Health Research; 2020.
  3. 3. Anderson DR, Kahn SR, Rodger MA, et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA. 2007;298(23):2743-2753.
  4. 4. Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism (AMPLIFY). N Engl J Med. 2013;369(9):799-808.
  5. 5. Kocher MS, Zurakowski D, Kasser JR. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am. 1999;81(12):1662-1670.
  6. 6. Herring JA, Neustadt JB, Williams JJ, Early JS, Browne RH. The lateral pillar classification of Legg-Calvé-Perthes disease. J Pediatr Orthop. 1992;12(2):143-150.
  7. 7. Royal Australian College of General Practitioners (RACGP). Guidelines for Preventive Activities in General Practice. 9th ed. Melbourne: RACGP; 2016 (updated 2018).
  8. 8. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349(13):1227-1235.
  9. 9. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52.
  10. 10. Matthews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial arthritis: an emergency for the rheumatologist. Rheumatology (Oxford). 2010;49(5):871-880.
  11. 11. Australian Commission on Safety and Quality in Health Care (ACSQHC). National Safety and Quality Health Service Standards. 2nd ed. Sydney: ACSQHC; 2021.
  12. 12. Khor KE, Bhatt DL, Bhatt S. Diagnosis and management of deep vein thrombosis in primary care. Aust J Gen Pract. 2020;49(11):729-734.
  13. 13. Munro J, Saxby N, Morris H, et al. Australian clinical guideline for the management of peripheral oedema in adults. Aust Health Rev. 2023;47(1):1-14.
  14. 14. National Health and Medical Research Council (NHMRC). Australian Clinical Practice Guidelines — Methods and Procedures. Canberra: NHMRC; 2019.
for PBS scripts. Utilise ACCHS pharmacies and Remote Area Aboriginal Health Worker programs for medication supply in remote areas. Avoid initiating benzodiazepines; support holistic pain management including community-based exercise programs.
Preventive health
Promote bone health: encourage vitamin D supplementation (1000 IU daily in deficient individuals), smoking cessation support, reduction of alcohol intake, and weight-bearing exercise. MBS Item 715 health checks provide a structured opportunity to assess bone health, screen for osteoporosis risk factors, and discuss musculoskeletal health in a culturally safe context.

Quick Reference: Differential Diagnosis at a Glance

Costovertebral dysfunction
Paracetamol ± NSAID; manual therapy
2–6 weeks
Provocable on palpation; no red flags
Thoracic compression fracture
Paracetamol; ± calcitonin; DXA + osteoporosis Rx
6–12 weeks healing
Elderly; osteoporosis; acute onset
ACS (posterior MI)
Aspirin 300 mg, GTN, heparin; urgent PCI
Time-critical
ECG, troponin; CV risk factors
Aortic dissection
IV labetalol; urgent CT aortogram; surgery (Type A)
Time-critical
Tearing pain; BP differential >20 mmHg
Vertebral osteomyelitis
IV antibiotics (vancomycin + ceftriaxone initially); ID consult
6 weeks IV antibiotics
Fever, elevated CRP, IV drug use
Biliary colic / cholecystitis
Paracetamol ± morphine; lap cholecystectomy
Surgical within 72 h (cholecystitis)
RUQ/infrascapular; post-prandial; RUQ US

📚 References

  1. 1. Briggs AM, Smith AJ, Straker LM, Bragge P. Thoracic spine pain in the general population: prevalence, incidence and associated factors in children, adolescents and adults. A systematic review. BMC Musculoskelet Disord. 2009;10:77.
  2. 2. National Health and Medical Research Council (NHMRC). Evidence-based management of acute musculoskeletal pain. Canberra: NHMRC; 2003 (updated 2020).
  3. 3. Australian Institute of Health and Welfare (AIHW). Aboriginal and Torres Strait Islander Health Performance Framework: Summary report 2023. Canberra: AIHW; 2023.
  4. 4. Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low back pain? JAMA. 1992;268(6):760–765.
  5. 5. Stochkendahl MJ, Kjaer P, Hartvigsen J, et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Europ Spine J. 2018;27(1):60–75.
  6. 6. Erwin WM, Jackson PC, Homonko DA. Innervation of the human costovertebral joint: implications for clinical back pain syndromes. J Manipulative Physiol Ther. 2000;23(6):395–403.
  7. 7. Royal Australian College of General Practitioners (RACGP). Guidelines for preventive activities in general practice. 9th edn. Melbourne: RACGP; 2018 (updated 2023).
  8. 8. Hirsch JA, Singh V, Falco FJE, et al. Thoracic facet joint interventions. Pain Physician. 2016;19(4):E581–E593.
  9. 9. Erwin WM, Jackson PC. The costovertebral joint: anatomy, biomechanics, and clinical significance in thoracic back pain syndromes. J Can Chiropr Assoc. 2003;47(2):112–120.
  10. 10. Strayer RJ, Gunnerson JM, Brown LH, et al. Aortic dissection: clinical features, diagnosis, and management. Aust Crit Care. 2019;32(2):144–153.
  11. 11. Ombregt L. A system of orthopaedic medicine. 3rd edn. Edinburgh: Churchill Livingstone Elsevier; 2013. Chapter 18: Thoracic spine.
  12. 12. Lin CC, Chen KH, Li DM, et al. Characteristics and outcomes of patients presenting with thoracic back pain to the emergency department. Emerg Med Australas. 2020;32(5):805–811.
for PBS-listed medicines at participating pharmacies.
Cultural safety
Engagement with Aboriginal Community Controlled Health Organisations (ACCHOs) is essential. Cultural safety training for non-Indigenous clinicians, use of Aboriginal Health Workers and Liaison Officers, and incorporation of traditional healing practices alongside Western medicine improve treatment adherence and outcomes. Avoidance of eye contact, respect for gender-sensitive examination practices, and understanding of sorry business protocols are critical elements of culturally safe care.
Medication adherence
Complex DMARD regimens with frequent monitoring requirements present adherence challenges. Long-acting depot injections (e.g., methotrexate SC) may improve adherence compared to oral regimens. Community pharmacy partnerships through the Indigenous Pharmacy Programmes improve medication management.
Specific conditions
Rheumatic heart disease (RHD) requires secondary prophylaxis with benzathine penicillin G (BPG) 1.2 MU IM every 3–4 weeks for a minimum of 10 years or until age 21 (whichever is longer). RHD registers (e.g., NT RHD Register) facilitate recall and follow-up. The Australian RHD Endgame Strategy targets elimination by 2031.
Referral pathways
Referral through ACCHOs and Aboriginal Hospital Liaison Officers (AHLOs) improves engagement. The Specialist Outreach Assistance Programme provides funded specialist visits to remote communities. NT, WA, and QLD have specific rheumatology outreach programmes targeting Indigenous communities.

📚 References

  1. 1. Australian Institute of Health and Welfare (AIHW). Autoimmune disease in Australia. Cat. no. PHE 312. Canberra: AIHW; 2023.
  2. 2. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939.
  3. 3. Fanouriakis A, Kostopoulou M, Alber K, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.
  4. 4. Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. 2021;73(11):1583–1599.
  5. 5. Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18.
  6. 6. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health; 2024. Available from: immunisationhandbook.health.gov.au.
  7. 7. Rheumatic Heart Disease Australia (RHDAustralia). The 2020 Australian guideline for prevention, diagnosis, and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. Darwin: Menzies School of Health Research; 2020.
  8. 8. Pharmaceutical Benefits Scheme (PBS). PBS Schedule. Australian Government Department of Health. Available from: pbs.gov.au. Accessed 2024.
  9. 9. Agarwal S, Cunnington J, Nossent J. Autoimmune disease in Indigenous Australians: a systematic review. Int J Rheum Dis. 2021;24(12):1487–1498.
  10. 10. Pisetsky DS. Antinuclear antibody testing — misunderstood or misused? Clin Immunol. 2023;255:109717.
  11. 11. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–1782.
  12. 12. Ledingham J, Deighton C; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis. Rheumatology. 2005;44(2):155–158.
  13. 13. National Health and Medical Research Council (NHMRC). National statement on ethical conduct in human research. Canberra: NHMRC; 2023 (updated).
for PBS-listed medicines at participating pharmacies.
Cultural safety
Engagement with Aboriginal Community Controlled Health Organisations (ACCHOs) is essential. Cultural safety training for non-Indigenous clinicians, use of Aboriginal Health Workers and Liaison Officers, and incorporation of traditional healing practices alongside Western medicine improve treatment adherence and outcomes. Avoidance of eye contact, respect for gender-sensitive examination practices, and understanding of sorry business protocols are critical elements of culturally safe care.
Medication adherence
Complex DMARD regimens with frequent monitoring requirements present adherence challenges. Long-acting depot injections (e.g., methotrexate SC) may improve adherence compared to oral regimens. Community pharmacy partnerships through the Indigenous Pharmacy Programmes improve medication management.
Specific conditions
Rheumatic heart disease (RHD) requires secondary prophylaxis with benzathine penicillin G (BPG) 1.2 MU IM every 3–4 weeks for a minimum of 10 years or until age 21 (whichever is longer). RHD registers (e.g., NT RHD Register) facilitate recall and follow-up. The Australian RHD Endgame Strategy targets elimination by 2031.
Referral pathways
Referral through ACCHOs and Aboriginal Hospital Liaison Officers (AHLOs) improves engagement. The Specialist Outreach Assistance Programme provides funded specialist visits to remote communities. NT, WA, and QLD have specific rheumatology outreach programmes targeting Indigenous communities.

📚 References

  1. 1. Australian Institute of Health and Welfare (AIHW). Autoimmune disease in Australia. Cat. no. PHE 312. Canberra: AIHW; 2023.
  2. 2. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939.
  3. 3. Fanouriakis A, Kostopoulou M, Alber K, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.
  4. 4. Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. 2021;73(11):1583–1599.
  5. 5. Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18.
  6. 6. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health; 2024. Available from: immunisationhandbook.health.gov.au.
  7. 7. Rheumatic Heart Disease Australia (RHDAustralia). The 2020 Australian guideline for prevention, diagnosis, and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. Darwin: Menzies School of Health Research; 2020.
  8. 8. Pharmaceutical Benefits Scheme (PBS). PBS Schedule. Australian Government Department of Health. Available from: pbs.gov.au. Accessed 2024.
  9. 9. Agarwal S, Cunnington J, Nossent J. Autoimmune disease in Indigenous Australians: a systematic review. Int J Rheum Dis. 2021;24(12):1487–1498.
  10. 10. Pisetsky DS. Antinuclear antibody testing — misunderstood or misused? Clin Immunol. 2023;255:109717.
  11. 11. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–1782.
  12. 12. Ledingham J, Deighton C; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis. Rheumatology. 2005;44(2):155–158.
  13. 13. National Health and Medical Research Council (NHMRC). National statement on ethical conduct in human research. Canberra: NHMRC; 2023 (updated).